[go: up one dir, main page]

WO2004033655A3 - Transporteur de solute organique humain - Google Patents

Transporteur de solute organique humain Download PDF

Info

Publication number
WO2004033655A3
WO2004033655A3 PCT/US2003/032087 US0332087W WO2004033655A3 WO 2004033655 A3 WO2004033655 A3 WO 2004033655A3 US 0332087 W US0332087 W US 0332087W WO 2004033655 A3 WO2004033655 A3 WO 2004033655A3
Authority
WO
WIPO (PCT)
Prior art keywords
transporters
agents
organic solute
substrates
human organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/032087
Other languages
English (en)
Other versions
WO2004033655A2 (fr
Inventor
Noa Zerangue
Christopher Paddon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XenoPort Inc
Original Assignee
XenoPort Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XenoPort Inc filed Critical XenoPort Inc
Priority to AU2003279917A priority Critical patent/AU2003279917A1/en
Priority to US10/763,644 priority patent/US20040161424A1/en
Publication of WO2004033655A2 publication Critical patent/WO2004033655A2/fr
Anticipated expiration legal-status Critical
Publication of WO2004033655A3 publication Critical patent/WO2004033655A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne plusieurs protéines transporteuses, des acides nucléiques codant pour celles-ci et des procédés utilisant les transporteurs à des agents de criblage, des conjugués ou des fractions de conjugués, liés ou pouvant être liés à des agents, en vue d'avoir la capacité d'être transportés en tant que substrats par les transporteurs. L'invention concerne également des procédés de traitement impliquant l'administration orale d'agents qui, soit seuls, soit à la suite de liaison à une fraction conjuguée, sont des substrats de l'un des transporteurs.
PCT/US2003/032087 2002-10-08 2003-10-08 Transporteur de solute organique humain Ceased WO2004033655A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003279917A AU2003279917A1 (en) 2002-10-08 2003-10-08 Human organic solute transporters
US10/763,644 US20040161424A1 (en) 2002-10-08 2004-01-22 Human organic solute transporters

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41729802P 2002-10-08 2002-10-08
US60/417,298 2002-10-08

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/763,644 Continuation-In-Part US20040161424A1 (en) 2002-10-08 2004-01-22 Human organic solute transporters

Publications (2)

Publication Number Publication Date
WO2004033655A2 WO2004033655A2 (fr) 2004-04-22
WO2004033655A3 true WO2004033655A3 (fr) 2005-06-23

Family

ID=32093997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/032087 Ceased WO2004033655A2 (fr) 2002-10-08 2003-10-08 Transporteur de solute organique humain

Country Status (2)

Country Link
AU (1) AU2003279917A1 (fr)
WO (1) WO2004033655A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452680B2 (en) 2004-01-30 2008-11-18 Xenoport, Inc. MCT1 transporters expressed in blood brain barrier cells
WO2006001986A2 (fr) * 2004-06-04 2006-01-05 Xenoport, Inc. Transporteurs glut3 exprimes dans des cellules cancereuses

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061471A2 (fr) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Proteines transmembranaires humaines
WO2001049728A2 (fr) * 2000-01-06 2001-07-12 Protegene Inc. Proteines humaines a domaines hydrophobes et adn codant ces proteines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061471A2 (fr) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Proteines transmembranaires humaines
WO2001049728A2 (fr) * 2000-01-06 2001-07-12 Protegene Inc. Proteines humaines a domaines hydrophobes et adn codant ces proteines

Also Published As

Publication number Publication date
AU2003279917A1 (en) 2004-05-04
WO2004033655A2 (fr) 2004-04-22
AU2003279917A8 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
WO2006040129A3 (fr) Conjugues de proteine utilisables en therapie, pour le diagnostic et en chromatographie
WO2007047834A3 (fr) Conjugués de peptides pour administration par voie orale pour traiter des maladies métaboliques
WO2004018000A3 (fr) Compositions et methodes de traitement du cancer a l'aide d'immunoconjugues cytotoxiques d'anticorps du cd44 et d'agents chimiotherapeutiques
WO2004005326A3 (fr) Conjugues de tubulysine
WO2002002638A3 (fr) Methodes de traitement de maladies rhumatismales a l'aide d'une molecule ctla4 soluble
EP2230254A3 (fr) Combinaisons thérapeutiques d'anticorps anti-igfr1
WO2004084950A3 (fr) Procedes et compositions de ciblage cellulaire
HUP0402626A3 (en) Photochemical internalization for virus-mediated molecule delivery into the cyosol
WO2006116475A3 (fr) Compositions immunostimulantes
WO2008013954A3 (fr) Sites de phosphorylation de la tyrosine
WO2008054597A3 (fr) Sites de phosphorylation de tyrosine
DK1207870T3 (da) Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
NL1028837A1 (nl) N-terminaal monogepegyleerde conjugaten van humaan groeihormoon en werkwijze voor de bereiding daarvan.
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
WO2006050930A3 (fr) Composes a molecules conjugues presentant une activite d'absorption de cellules ameliorees
WO2006047631A3 (fr) Composes antimitotiques antiproliferatifs
EP1153607A3 (fr) Hormone de croissance pour le traitement de l'inflammation articulaire
WO2008013934A3 (fr) Sites de phosphorylation de tyrosines
WO2007064968A3 (fr) Compositions pharmaceutiques stables de 5,10 methylenetetrahydrofolate
WO2005042566A3 (fr) Peptides pour traitement et prevention de l'endometriose
AU2002309122A1 (en) Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes
WO2008021542A3 (fr) Sites d'acétylation de la lysine
WO2000062808A8 (fr) Conjugues de cobalamine utilises comme agents antitumoraux
WO2005041881A8 (fr) Conjugues taxoide/acide gras et preparations les contenant
WO2004033655A3 (fr) Transporteur de solute organique humain

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 10763644

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP